Friday, October 29, 2010

7:00 am : Breakfast and Exhibits

Session 4: Risk, Staging and Diagnosis
Session Chair: Nora Hansen, MD

8:00 am : Update on Breast Cancer Genetics
Claudine Isaacs, MD

8:30 am : Is It Reasonable to Give Tamoxifen to BRCA Mutation Carriers?
Priscilla Furth, MD

9:00 am :Breast Cancer Chemo Prevention:  Have We Made Progress?
V. Craig Jordan, OBE, PhD, DSc

9:30 am : Breast Cancer: Eyes to Thighs
Maxine Jochelson, MD

10:00 am : Questions and Answers

10:15 am : Break

10:30 - 11:15 am : Debate
Screening Mammography 2010: The USPHS Guidelines are Appropriate
Pro: Eric Winer, MD
Con: Connie Lehman, MD

11:15 am : Lynn Sage Distinguished Lecturer
Estrogen, Progestins and Risk of Breast Cancer
Malcolm Pike, PhD

12:00 pm : Lunch Break and Dessert with Exhibitors


Session 5: New Agents, Radiation and Reconstruction
Session Chair: Monica Morrow, MD

1:45 pm : Is the TNM Staging System Relevant in 2010?
Daniel Hayes, MD

2:15 pm : Is Trastuzumab Indicated for T1ab NO Cancers Overexpressing HER2
William Gradishar, MD

2:45 pm : New Targets for Systemic Therapy of Breast Cancer
Joyce O’Shaughnessy, MD

3:15 pm : Questions and Answers

3:30 pm : Break

3:45 pm : Breast Reconstruction 2010: Status and Outcomes
Amy Alderman, MD, MPD

4:15 pm : Debate : Patients at High Risk for PMRT Should Avoid Reconstruction
Pro: Jay Harris, MD
Con: Beryl McCormick, MD

5:15 pm : Questions and Answers

5:30 pm : Adjourn

5:30 pm - 7:00 pm : Welcome Reception